Technical Analysis for PRQR - ProQR Therapeutics B.V.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Spinning Top | Other | 1.04% | |
Bollinger Band Squeeze | Range Contraction | 1.04% | |
BB Squeeze + Lower Band Touch | Range Contraction | 1.04% | |
Lower Bollinger Band Touch | Weakness | 1.04% | |
Fell Below 20 DMA | Bearish | 1.57% | |
Bollinger Band Squeeze | Range Contraction | 1.57% | |
Earnings Movers | Other | 1.57% | |
BB Squeeze + Lower Band Touch | Range Contraction | 1.57% |
Alert | Time |
---|---|
Fell Below Lower Bollinger Band | 3 days ago |
Rose Above Previous Day's High | 3 days ago |
20 DMA Resistance | 3 days ago |
10 DMA Resistance | 3 days ago |
Up 3% | 3 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Genetic Disorder Therapeutic Gene Modulation Treatment Of Cystic Fibrosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Genetic Disorder Therapeutic Gene Modulation Treatment Of Cystic Fibrosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.29 |
52 Week Low | 1.11 |
Average Volume | 165,537 |
200-Day Moving Average | 1.81 |
50-Day Moving Average | 2.13 |
20-Day Moving Average | 1.98 |
10-Day Moving Average | 1.97 |
Average True Range | 0.12 |
RSI (14) | 42.20 |
ADX | 15.99 |
+DI | 18.72 |
-DI | 16.47 |
Chandelier Exit (Long, 3 ATRs) | 1.80 |
Chandelier Exit (Short, 3 ATRs) | 2.18 |
Upper Bollinger Bands | 2.04 |
Lower Bollinger Band | 1.91 |
Percent B (%b) | 0.2 |
BandWidth | 6.48 |
MACD Line | -0.04 |
MACD Signal Line | -0.04 |
MACD Histogram | 0.0013 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.05 | ||||
Resistance 3 (R3) | 2.05 | 2.03 | 2.03 | ||
Resistance 2 (R2) | 2.03 | 2.00 | 2.02 | 2.02 | |
Resistance 1 (R1) | 1.98 | 1.98 | 1.98 | 1.98 | 2.02 |
Pivot Point | 1.96 | 1.96 | 1.95 | 1.95 | 1.96 |
Support 1 (S1) | 1.91 | 1.93 | 1.91 | 1.91 | 1.86 |
Support 2 (S2) | 1.89 | 1.91 | 1.88 | 1.86 | |
Support 3 (S3) | 1.84 | 1.89 | 1.85 | ||
Support 4 (S4) | 1.84 |